Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
August-2014 Volume 8 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
August-2014 Volume 8 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Hydrogen sulfide reduces kidney injury due to urinary‑derived sepsis by inhibiting NF-κB expression, decreasing TNF-α levels and increasing IL-10 levels

  • Authors:
    • Xian Chen
    • Wujun Xu
    • Yi Wang
    • Hongmei Luo
    • Suqin Quan
    • Jing Zhou
    • Ning Yang
    • Tao Zhang
    • Lei Wu
    • Jun Liu
    • Xiangyang Long
    • Neng Zhu
    • Huang Xie
    • Zhigang Luo
  • View Affiliations / Copyright

    Affiliations: Department of Urology, Second Affiliated Hospital of University of South China, Hengyang, Hunan 421001, P.R. China, Department of Histology and Embryology, University of South China, Hengyang, Hunan 421001, P.R. China
  • Pages: 464-470
    |
    Published online on: June 12, 2014
       https://doi.org/10.3892/etm.2014.1781
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The present study aimed to investigate the effect of hydrogen sulfide (H2S) on kidney injury induced by urinary‑derived sepsis. Rabbits were randomly divided into control, sham, sepsis, NaHS 2.8 µmol/kg and NaHS 8.4 µmol/kg groups, with six rabbits in each group. Upper urinary tract obstruction and acute infection was induced to establish the sepsis model. Blood was collected to carry out a white blood cell (WBC) count, and creatinine (Cr) and blood urea nitrogen (BUN) analysis. Morphological changes were observed by hematoxylin and eosin (H&E) staining and transmission electron microscopy. Immunohistochemical staining was used to detect the expression levels of tumor necrosis factor (TNF)‑α, interleukin (IL)‑10 and nuclear factor κ-light-chain-enhancer of activated B cells (NF‑κB). Cystathionine‑γ‑lyase (CSE) activity was measured by the spectrophotometric methylene blue method and the blood H2S concentration was measured by deproteinization. WBC, Cr and BUN levels were significantly elevated in the sepsis group compared with those in the control group (P<0.05). Following treatment with NaHS, the WBC, Cr and BUN levels were significantly decreased in the NaHS groups compared with those in the sepsis group (P<0.05). The pathological features of kidney injury were also alleviated by NaHS. In the sepsis group, the levels of TNF‑α, IL‑10 and NF‑κB were significantly increased compared with those in the control group (P<0.05). In the NaHS groups, the TNF‑α and NF‑κB levels were significantly reduced whereas the IL‑10 level was significantly increased compared with the respective levels in the sepsis group (P<0.05). The H2S concentration was significantly decreased in the sepsis group and this reduction was attenuated in the NaHS groups (P<0.05). Furthermore, the NaHS 8.4 µmol/kg dose revealed a more potent effect than the NaHS 2.8 µmol/kg dose. Thus, exogenous H2S reduced kidney injury from urinary‑derived sepsis by decreasing the levels of NF‑κB and TNF‑α, and increasing the level of IL‑10.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Farshad S, Ranjbar R, Japoni A, et al: Microbial susceptibility, virulence factors, and plasmid profiles of uropathogenic Escherichia coli strains isolated from children in Jahrom, Iran. Arch Iran Med. 15:312–316. 2012.PubMed/NCBI

2 

Bagshaw SM, George C and Bellomo R: ANZICS Database Management Committee: Early acute kidney injury and sepsis: a multicentre evaluation. Crit Care. 12:R472008. View Article : Google Scholar : PubMed/NCBI

3 

Sadik NA, Mohamed WA and Ahmed MI: The association of receptor of advanced glycated end products and inflammatory mediators contributes to endothelial dysfunction in a prospective study of acute kidney injury patients with sepsis. Mol Cell Biochem. 359:73–81. 2012. View Article : Google Scholar

4 

Souza AC, Volpini RA, Shimizu MH, et al: Erythropoietin prevents sepsis-related acute kidney injury in rats by inhibiting NF-κB and upregulating endothelial nitric oxide synthase. Am J Physiol Renal Physiol. 302:F1045–1054. 2012.PubMed/NCBI

5 

Makkonen J, Pietiläinen KH, Rissanen A, et al: Genetic factors contribute to variation in serum alanine aminotransferase activity independent of obesity and alcohol: a study in monozygotic and dizygotic twins. J Hepatol. 50:1035–1042. 2009. View Article : Google Scholar

6 

Kimura H: Hydrogen sulfide: its production, release and functions. Amino Acids. 41:113–121. 2011. View Article : Google Scholar : PubMed/NCBI

7 

Calvert JW, Coetzee WA and Lefer DJ: Novel insights into hydrogen sulfide-mediated cytoprotection. Antioxid Redox Signal. 12:1203–1217. 2010. View Article : Google Scholar : PubMed/NCBI

8 

Zhou CF and Tang XQ: Hydrogen sulfide and nervous system regulation. Chin Med J (Engl). 124:3576–3582. 2011.PubMed/NCBI

9 

Bełtowski J: Hypoxia in the renal medulla: implications for hydrogen sulfide signaling. J Pharmacol Exp Ther. 334:358–363. 2010.PubMed/NCBI

10 

Pan LL, Liu XH, Gong QH, et al: Hydrogen sulfide attenuated tumor necrosis factor-α-induced inflammatory signaling and dysfunction in vascular endothelial cells. PLoS One. 6:e197662011.

11 

Tokuda K, Kida K, Marutani E, et al: Inhaled hydrogen sulfide prevents endotoxin-induced systemic inflammation and improves survival by altering sulfide metabolism in mice. Antioxid Redox Signal. 17:11–21. 2012. View Article : Google Scholar : PubMed/NCBI

12 

Ang SF, Sio SW, Moochhala SM, et al: Hydrogen sulfide upregulates cyclooxygenase-2 and prostaglandin E metabolite in sepsis-evoked acute lung injury via transient receptor potential vanilloid type 1 channel activation. J Immunol. 187:4778–4787. 2011. View Article : Google Scholar

13 

Chattopadhyay M, Kodela R, Nath N, et al: Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo. Biochem Pharmacol. 83:723–732. 2012.PubMed/NCBI

14 

Sen N, Paul BD, Gadalla MM, et al: Hydrogen sulfide-linked sulfhydration of NF-κB mediates its antiapoptotic actions. Mol Cell. 45:13–24. 2012.PubMed/NCBI

15 

Chen X, Wang Y, Luo H, et al: Ulinastatin reduces urinary sepsis-related inflammation by upregulating IL-10 and downregulating TNF α levels. Mol Med Rep. 8:29–34. 2013.PubMed/NCBI

16 

Payen D, Lukaszewicz AC, Legrand M, et al: A multicenter study of acute kidney injury in severe sepsis and septic shock: association with inflammatory phenotype and HLA genotype. PLoS One. 7:e358382012. View Article : Google Scholar : PubMed/NCBI

17 

Li L, Salto-Tellez M, Tan CH, et al: GYY4137, a novel hydrogen sulfide-releasing molecule, protects against endotoxic shock in the rat. Free Radic Biol Med. 47:103–113. 2009. View Article : Google Scholar

18 

Yang C, Yang Z, Zhang M, et al: Hydrogen sulfide protects against chemical hypoxia-induced cytotoxicity and inflammation in HaCaT cells through inhibition of ROS/NF-κB/COX-2 pathway. PLoS One. 6:e219712011.PubMed/NCBI

19 

Pan LL, Liu XH, Gong QH, et al: Hydrogen sulfide attenuated tumor necrosis factor-α-induced inflammatory signaling and dysfunction in vascular endothelial cells. PLoS One. 6:e197662011.

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Chen X, Xu W, Wang Y, Luo H, Quan S, Zhou J, Yang N, Zhang T, Wu L, Liu J, Liu J, et al: Hydrogen sulfide reduces kidney injury due to urinary‑derived sepsis by inhibiting NF-κB expression, decreasing TNF-α levels and increasing IL-10 levels. Exp Ther Med 8: 464-470, 2014.
APA
Chen, X., Xu, W., Wang, Y., Luo, H., Quan, S., Zhou, J. ... Luo, Z. (2014). Hydrogen sulfide reduces kidney injury due to urinary‑derived sepsis by inhibiting NF-κB expression, decreasing TNF-α levels and increasing IL-10 levels. Experimental and Therapeutic Medicine, 8, 464-470. https://doi.org/10.3892/etm.2014.1781
MLA
Chen, X., Xu, W., Wang, Y., Luo, H., Quan, S., Zhou, J., Yang, N., Zhang, T., Wu, L., Liu, J., Long, X., Zhu, N., Xie, H., Luo, Z."Hydrogen sulfide reduces kidney injury due to urinary‑derived sepsis by inhibiting NF-κB expression, decreasing TNF-α levels and increasing IL-10 levels". Experimental and Therapeutic Medicine 8.2 (2014): 464-470.
Chicago
Chen, X., Xu, W., Wang, Y., Luo, H., Quan, S., Zhou, J., Yang, N., Zhang, T., Wu, L., Liu, J., Long, X., Zhu, N., Xie, H., Luo, Z."Hydrogen sulfide reduces kidney injury due to urinary‑derived sepsis by inhibiting NF-κB expression, decreasing TNF-α levels and increasing IL-10 levels". Experimental and Therapeutic Medicine 8, no. 2 (2014): 464-470. https://doi.org/10.3892/etm.2014.1781
Copy and paste a formatted citation
x
Spandidos Publications style
Chen X, Xu W, Wang Y, Luo H, Quan S, Zhou J, Yang N, Zhang T, Wu L, Liu J, Liu J, et al: Hydrogen sulfide reduces kidney injury due to urinary‑derived sepsis by inhibiting NF-κB expression, decreasing TNF-α levels and increasing IL-10 levels. Exp Ther Med 8: 464-470, 2014.
APA
Chen, X., Xu, W., Wang, Y., Luo, H., Quan, S., Zhou, J. ... Luo, Z. (2014). Hydrogen sulfide reduces kidney injury due to urinary‑derived sepsis by inhibiting NF-κB expression, decreasing TNF-α levels and increasing IL-10 levels. Experimental and Therapeutic Medicine, 8, 464-470. https://doi.org/10.3892/etm.2014.1781
MLA
Chen, X., Xu, W., Wang, Y., Luo, H., Quan, S., Zhou, J., Yang, N., Zhang, T., Wu, L., Liu, J., Long, X., Zhu, N., Xie, H., Luo, Z."Hydrogen sulfide reduces kidney injury due to urinary‑derived sepsis by inhibiting NF-κB expression, decreasing TNF-α levels and increasing IL-10 levels". Experimental and Therapeutic Medicine 8.2 (2014): 464-470.
Chicago
Chen, X., Xu, W., Wang, Y., Luo, H., Quan, S., Zhou, J., Yang, N., Zhang, T., Wu, L., Liu, J., Long, X., Zhu, N., Xie, H., Luo, Z."Hydrogen sulfide reduces kidney injury due to urinary‑derived sepsis by inhibiting NF-κB expression, decreasing TNF-α levels and increasing IL-10 levels". Experimental and Therapeutic Medicine 8, no. 2 (2014): 464-470. https://doi.org/10.3892/etm.2014.1781
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team